Cen FYS, Jiménez TI, Chaverri PG, Marín CA, Elizondo VJR

Idioma: Español
Referencias bibliográficas: 19
Paginas: 1-10
Archivo PDF: 147.61 Kb.

RESUMEN

La migraña es una condición crónica de carácter neurovascular, episódico y multifactorial; afecta a hombres y mujeres en todo el mundo. Es causada por actores genéticos y ambientales. La presentación clínica consiste en cefalea recurrente, ésta puede ser pulsátil o no y se puede asociar a nauseas, vomito, fotofobia o fonofobia. Se realizan estudios de neuroimagen en presencia de banderas rojas de cefalea. El tratamiento del dolor agudo se determina según la severidad y la frecuencia de los ataques de migraña y la toma o no de medicacion previa.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Jes O; André B; Robert K et al. International headache society, The International Classification of Headache Disorders, 3rd edition. Headache Classification Committee of the International Headache Society (IHS). 2018; Vol 38 (Núm1): 18-28.

2. Anjel B. Morbidity and mortality weekly, M.M.W.R, QuickStats: Percentage* of Adults Aged ≥18 Years Who Reported Having a Severe Headache or Migraine in the Past 3 Months, † by Sex and Age Group. National Health Interview Survey, § United States 2015;66(24) (Núm 1): 654.

3. Lipton R, Bigal. M, Diamond M, Reed M, Stewart W. et al. Migraine prevalence, disease burden, and the need for preventive therapy. AAN Enterprises, Inc. January 30, 2007; NEUROLOGY 68(1): 343-349

4. Carlos B, Maria Carla B. Migraña. Elsevier, Neurología Argentina. junio 2013; Vol 5 (Núm 2): 94,95.

5. Jadwiga L, Glen S. Migraine prophylaxis: who, why, and how. CLEVELAND CLINIC JOURNAL OF MEDICINE. septiembre 2006;73(Núm 9): 793-814.

6. F Michael C. Pathophysiology of Migraine. Medical Publishers, Inc. 2006; SEMINARS IN NEUROLOGY, 26 (Núm2): 171-177.

7. Werner J. Becke, W.J.B. The Diagnosis and Management of Chronic Migraine in Primary Care. American Headache Society. Mayo 2017;57(9): 1471- 1479.

8. Serena C, Smita P, Tim R, Martin U. Diagnosis and management of headaches in young people and adults: summary of NICE guidance. BMJ. September 2012; Guidelines.

9. Annette D, Franz J.W, Daniel F.H, Ashley H.A, Sepideh A.H. Appropriateness Criteria Headache. American College of Radiology. 2014; Vol. (Num.): 1-9

10. Michael.D, Devon R.M, Mark B, George A.T, Douglas C.M. Does This Patient with Headache Have a Migraine or NeedNeuroimaging? JAMA. 2006;296(10): 1274-1282

11. Serena L.O, Benjamin W.F, Suzanne C, Mia T.M, Cynthia B. Management of Adults with Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies. Wiley Periodicals, Inc. June, 2016; Vol56 (1): 911-936.

12. Silberstein S, Todd J.S. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Wiley Periodicals, Inc. January 2015;55 (Num): 3-20.

13. Laurence L.B, Bruce a chabner, B.C, Björn c knollmann, B.K. Goodman & Gilman: Las Bases Farmacológicas De La Terapéutic. (13ed ed.). Ciudad de México, México: McGraw-Hill Global Education Holdings, LLC; 2018.

14. Stephen D.S. Current management: migraine headache. ASAP/Cambridge University. 2017;17(45,26): 4-10.

15. Michael R, Peter R, Barnet E, John R.A. ED Treatment of migraine patients has changed. American Journal of Emergency Medicine. 2015;22(1): 2-8.

16. Tina B.M, Sydney M. Toronto Notes. (34ed ed.). Totonto, Canada; 2018.

17. Mojtaba K, Nahid H.N, Fateme Y.A, Mohammad T, Soudeh S.G. Effectiveness of intravenous dexamethasone, metoclopramide, ketorolac, and chlorpromazine for pain relief and prevention of recurrence in the migraine headache: a prospective double-blind randomized clinical trial. Neurological Sciences, Springer. February 2019;1(1): 1-7.

18. Kasra M, Stewart T, Jennifer S.K. Menstrual Migraine and Treatment Options: Review. Wiley Periodicals, 2016 American Headache Society; Vol.1(1): 194-204.

19. Stephen D.S. Practice parameter: Evidence-based guidelines for migraine headache (an evidencebased review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. AAN Enterprises, Inc. 2000;55(6): 754- 752.